ARTICLE | Company News
Zydus sales and marketing update
December 15, 2014 8:00 AM UTC
Zydus launched Exemptia, a biosimilar of adalimumab, in India to treat autoimmune disorders including rheumatoid arthritis (RA), juvenile idiopathic arthritis, psoriatic arthritis and ankylosing spon...